Dynein function and protein clearance changes in tumor cells induced by a Kunitz-type molecule, Amblyomin-X.
Amblyomin-X is a Kunitz-type recombinant protein identified from the transcriptome of the salivary glands of the tick Amblyomma cajennense and has anti-coagulant and antitumoral activity. The supposed primary target of this molecule is the proteasome system. Herein, we elucidated intracellular event...
Main Authors: | Mario T F Pacheco, Carolina M Berra, Kátia L P Morais, Juliana M Sciani, Vania G Branco, Rosemary V Bosch, Ana M Chudzinski-Tavassi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0111907 |
Similar Items
-
Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity
by: Durvanei A. Maria, et al.
Published: (2019-01-01) -
Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells
by: Mariana Costa Braga Schmidt, et al.
Published: (2020-01-01) -
New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X
by: Lorena Favaro Pavon, et al.
Published: (2019-07-01) -
Avaliação dos efeitos de um inibidor do tipo Kunitz (Amblyomin-X) em culturas celulares de carcinoma renal
by: Akagi, Erica Mie [UNIFESP]
Published: (2015) -
Corrigendum to “Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma “in vitro” [Biomed. Pharmacother. 66 (2012) 64–69]
by: Erica Mie Akagi, et al.
Published: (2019-10-01)